A phase II/III biomarker-driven trial for Second Line Therapy of Squamous Cell Lung Cancer

Cancer, Cancer - Lung
John McCann, MD
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
The purpose of this study is to perform tests on genes and proteins produced by genes in your tumor sample for certain features that investigational targeted agents used in this study are specifically designed to work against. Then, if your tumor begins to grow, the purpose is to assign you to a treatment sub-study that is chosen based on the results (genes and proteins called “biomarkers”) of this genetic testing on your tumor sample.
Squamous cell lung cancer
Betsy Lopez